R. Ozaras Et Al. , "Occult Hepatitis B and Risk of Reactivation After Hepatitis C Treatment With Direct-Acting Antivirals," CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , vol.15, no.4, pp.605, 2017
Ozaras, R. Et Al. 2017. Occult Hepatitis B and Risk of Reactivation After Hepatitis C Treatment With Direct-Acting Antivirals. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , vol.15, no.4 , 605.
Ozaras, R., Mete, B., & Tabak, F., (2017). Occult Hepatitis B and Risk of Reactivation After Hepatitis C Treatment With Direct-Acting Antivirals. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , vol.15, no.4, 605.
Ozaras, Reşat, Bilgül METE, And Ömer Fehmi TABAK. "Occult Hepatitis B and Risk of Reactivation After Hepatitis C Treatment With Direct-Acting Antivirals," CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , vol.15, no.4, 605, 2017
Ozaras, Reşat Et Al. "Occult Hepatitis B and Risk of Reactivation After Hepatitis C Treatment With Direct-Acting Antivirals." CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , vol.15, no.4, pp.605, 2017
Ozaras, R. Mete, B. And Tabak, F. (2017) . "Occult Hepatitis B and Risk of Reactivation After Hepatitis C Treatment With Direct-Acting Antivirals." CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , vol.15, no.4, p.605.
@article{article, author={Reşat ÖZARAS Et Al. }, title={Occult Hepatitis B and Risk of Reactivation After Hepatitis C Treatment With Direct-Acting Antivirals}, journal={CLINICAL GASTROENTEROLOGY AND HEPATOLOGY}, year=2017, pages={605} }